Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.

Literature DB >> 25830521

Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.

Kylie M Drake¹, Suzy A Comhair, Serpil C Erzurum, Rubin M Tuder, Micheala A Aldred.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Smad8 Protein

Year: 2015 PMID： 25830521 PMCID： PMC4407488 DOI： 10.1164/rccm.201411-1985LE

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

22 in total

Review 1. Role of bone morphogenetic proteins in cardiac differentiation.

Authors: Bram van Wijk; Antoon F M Moorman; Maurice J B van den Hoff
Journal: Cardiovasc Res Date: 2006-11-21 Impact factor: 10.787

Review 2. Updated clinical classification of pulmonary hypertension.

Authors: Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal: J Am Coll Cardiol Date: 2009-06-30 Impact factor: 24.094

3. The branching programme of mouse lung development.

Authors: Ross J Metzger; Ophir D Klein; Gail R Martin; Mark A Krasnow
Journal: Nature Date: 2008-05-07 Impact factor: 49.962

4. Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Authors: Micheala A Aldred; Suzy A Comhair; Marileila Varella-Garcia; Kewal Asosingh; Weiling Xu; George P Noon; Patricia A Thistlethwaite; Rubin M Tuder; Serpil C Erzurum; Mark W Geraci; Christopher D Coldren
Journal: Am J Respir Crit Care Med Date: 2010-06-25 Impact factor: 21.405

5. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.

Authors: D Hunter Best; Cecily Vaughn; Jamie McDonald; Kristy Damjanovich; James R Runo; Jason M Chibuk; Pinar Bayrak-Toydemir
Journal: J Med Genet Date: 2011-03-04 Impact factor: 6.318

6. Shear stress inhibits apoptosis of human endothelial cells.

Authors: S Dimmeler; J Haendeler; V Rippmann; M Nehls; A M Zeiher
Journal: FEBS Lett Date: 1996-12-09 Impact factor: 4.124

7. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

Authors: David B Badesch; Gary E Raskob; C Greg Elliott; Abby M Krichman; Harrison W Farber; Adaani E Frost; Robyn J Barst; Raymond L Benza; Theodore G Liou; Michelle Turner; Scott Giles; Kathy Feldkircher; Dave P Miller; Michael D McGoon
Journal: Chest Date: 2009-10-16 Impact factor: 9.410

8. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.

Authors: M Shintani; H Yagi; T Nakayama; T Saji; R Matsuoka
Journal: J Med Genet Date: 2009-02-11 Impact factor: 6.318

9. Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation.

Authors: Jamie McDonald; Friederike Gedge; Allene Burdette; James Carlisle; Changkuoth Jock Bukjiok; Michelle Fox; Pinar Bayrak-Toydemir
Journal: J Mol Diagn Date: 2009-09-18 Impact factor: 5.568

10. Defective pulmonary vascular remodeling in Smad8 mutant mice.

Authors: Zheng Huang; Degang Wang; Kaori Ihida-Stansbury; Peter Lloyd Jones; James F Martin
Journal: Hum Mol Genet Date: 2009-05-05 Impact factor: 6.150

12 in total

1. Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.

Authors: Eric D Austin; James West; James E Loyd; Anna R Hemnes
Journal: Am J Respir Crit Care Med Date: 2017-01-01 Impact factor: 21.405

Review 2. Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

Authors: Soni Savai Pullamsetti; Rajkumar Savai; Werner Seeger; Elena A Goncharova
Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405

Review 3. ALK1 signaling in development and disease: new paradigms.

Authors: Beth L Roman; Andrew P Hinck
Journal: Cell Mol Life Sci Date: 2017-09-04 Impact factor: 9.261

Review 4. 'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors: Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal: Genes (Basel) Date: 2020-11-26 Impact factor: 4.096

5. Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.

Authors: Chiara Federici; Kylie M Drake; Christina M Rigelsky; Lauren N McNelly; Sirena L Meade; Suzy A A Comhair; Serpil C Erzurum; Micheala A Aldred
Journal: Am J Respir Crit Care Med Date: 2015-07-15 Impact factor: 21.405

6. Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors: Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal: Pulm Circ Date: 2019-11-20 Impact factor: 3.017